Mycenax Biotech Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Pei-Jiun Chen
Chief executive officer
NT$7.6m
Total compensation
| CEO salary percentage | 47.7% |
| CEO tenure | 1.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -NT$683m |
| Sep 30 2023 | n/a | n/a | -NT$713m |
| Jun 30 2023 | n/a | n/a | -NT$764m |
| Mar 31 2023 | n/a | n/a | -NT$713m |
| Dec 31 2022 | NT$8m | NT$4m | -NT$454m |
Compensation vs Market: Pei-Jiun's total compensation ($USD233.71K) is above average for companies of similar size in the TW market ($USD164.81K).
Compensation vs Earnings: Insufficient data to compare Pei-Jiun's compensation with company performance.
CEO
Pei-Jiun Chen
1.6yrs
Tenure
NT$7,609,000
Compensation
Ms. Pei-Jiun Chen is Representative Director of Mycenax Biotech Inc. from October 06, 2022 and serves as its Chairman since October 6, 2022 and Chief executive Officer and President. She is Chief Executive...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President CEO & Chairman | 1.6yrs | NT$7.61m | no data | |
| Independent Director | 2yrs | NT$246.00k | no data | |
| Director | less than a year | no data | no data | |
| Director | no data | NT$70.00k | no data | |
| Director | 4.8yrs | NT$75.00k | no data | |
| Director | 2.9yrs | NT$75.00k | no data | |
| Independent Director | 11.2yrs | NT$405.00k | no data | |
| Independent Director | 4.8yrs | NT$390.00k | no data | |
| Director | 1.4yrs | no data | no data |
2.5yrs
Average Tenure
Experienced Board: 4726's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.